ReviewGynecologic oncology reports2024

Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer.

Shashank Sama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.